| Financial Year |
March 31 2023 |
| Monetary Funds |
434,712,826.97 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
70,814,186.46 |
| Accounts Receivable |
756,664,455.46 |
| Advances to Suppliers |
74,477,779.50 |
| Other Receivables |
16,418,636.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
835,967,035.56 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
72,812,576.72 |
| Total Current Assets |
2,371,806,095.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,408,789.96 |
| Investment Properties |
-- |
| Fixed Assetes |
657,924,000.18 |
| Under-construction Projects |
278,030,224.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
138,735,848.53 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
13,482,434.43 |
| Deferred Income Tax Assets |
23,919,733.34 |
| Other Non-Current Assets |
173,078,776.84 |
| Sub-Total of Non-Current Assets |
1,290,638,570.70 |
| Total Assets |
3,662,444,665.77 |
| Short-Term Loans |
523,655,083.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
360,835,511.39 |
| Accounts Payable |
585,450,706.37 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,579,901.21 |
| Taxes Payable |
35,585,482.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
9,332,872.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
235,411,291.24 |
| Other Current Liabilities |
81,706,953.66 |
| Sub-Total of Current Liabilities |
2,506,628,947.20 |
| Long-term Loans |
109,550,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
12,194,419.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
25,107,710.31 |
| Deferred Income Tax Liabilities |
324,056.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
178,673,463.37 |
| Total Liabilities |
2,685,302,410.57 |
| Paid-In Capital(Or Share Stock) |
88,655,041.00 |
| Capital Surplus |
504,422,124.95 |
| Surplus Reserve |
44,327,520.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
304,993,034.67 |
| Minority Stockholder's Interest |
34,119,192.31 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
943,023,062.89 |
| Owner's Equity（Stockholder's Equity） |
977,142,255.20 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,662,444,665.77 |
